Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06450132 · ClinicalTrials.gov registry record · Phase 4
Changes in Eye Shape With Myopia Management Interventions
A Phase 4 study of Myopia, sponsored by Ohio State University.
- Active
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06450132 is a Phase 4 study of Myopia that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 75 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06450132, a Phase 4 study of Myopia, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to study changes in eye shape of nearsighted young adults using low-dose atropine eye drops or soft multifocal contact lenses. The main questions it aims to answer are: * do low-dose atropine and soft multifocal contact lenses affect the shape of the peripheral eye? * are changes in peripheral eye shape from these interventions influenced by changes in the focusing system of the eye? Participants will: * have multiple different types of photos taken * have their prescription for glasses/contacts checked * have their eye health checked, including the use of dilating eye drops * be randomly assigned to use eye drops every night or wear special contact lenses daily instead of their typical contacts * will complete five study visits over the course of 12 months Researchers will compare young adults using low-dose atropine to those wearing soft multifocal contact lenses and to those using no intervention to see if using these interventions affects retinal shape.
Conditions Studied
Interventions
- DRUG Atropine Ophthalmic
- DEVICE MiSight 1-day disposable contact lenses
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06450132
The ClinicalTrials.gov registry entry for NCT06450132 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (72% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Atropine Ophthalmic is the first listed.
NCT06450132 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06450132 about?
NCT06450132 is a clinical study titled "Changes in Eye Shape With Myopia Management Interventions". The goal of this clinical trial is to study changes in eye shape of nearsighted young adults using low-dose atropine eye drops or soft multifocal contact lenses. The main questions it aims to answer are: * do low-dose atropine and soft multifocal contact lenses affect the shape of the peripheral ey...
What is the current status of trial NCT06450132?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2024-08-01. Estimated completion is 2026-07-31.
What conditions does trial NCT06450132 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT06450132?
The interventions under investigation include: Atropine Ophthalmic (DRUG), MiSight 1-day disposable contact lenses (DEVICE).
Who is sponsoring clinical trial NCT06450132?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06450132 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK
COMPLETED · Phase 4
-
The Influence of Atropine on Choroidal Thickness
COMPLETED · Phase 4
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.